Short-term cost-effectiveness of psychodynamic therapy and cognitive-behavioral therapy in social anxiety disorder: Results from the SOPHO-NET trial

Journal of Affective Disorders

Volumn 180, Issue , 2015, Pages 21-28

  Egger, Nina ^a   Konnopka, Alexander ^a   Beutel, Manfred E ^b   Herpertz, Stephan ^c   Hiller, Wolfgang ^b   Hoyer, Juergen ^d   Salzer, Simone ^e   Stangier, Ulrich ^f   Strauss, Bernhard ^g   Willutzki, Ulrike ^h   Wiltink, Joerg ^b   Leichsenring, Falk ⁱ   Leibing, Eric ^e   König, Hans Helmut ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^e UNIVERSITY OF GÖTTINGEN   (Germany)

^f GOETHE UNIVERSITY   (Germany)

^g JENA UNIVERSITY HOSPITAL   (Germany)

^h UNIVERSITY OF WITTEN HERDECKE   (Germany)

ⁱ JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Cognitive behavioral therapy; Cost effectiveness; Economic evaluation; Psychodynamic therapy; Social anxiety disorder

Indexed keywords

ABSENTEEISM; ADULT; AGED; ARTICLE; COGNITIVE THERAPY; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DISEASE SEVERITY; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; PSYCHODYNAMIC PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; SOCIAL PHOBIA; COMPARATIVE STUDY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ECONOMICS; MENTAL HEALTH SERVICE; MIDDLE AGED; PHOBIC DISORDERS; PROCEDURES; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; TIME; TREATMENT OUTCOME; UTILIZATION;

COGNITIVE THERAPY; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; MENTAL HEALTH SERVICES; MIDDLE AGED; PHOBIC DISORDERS; TIME FACTORS; TREATMENT OUTCOME; WAITING LISTS;

EID: 84927155111     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2015.03.037     Document Type: Article

References (59)

1. C. Acarturk, P. Cuijpers, A. van Straten, and R. de Graaf Psychological treatment of social anxiety disorder: a meta-analysis Psychol. Med. 39 2009 241 254
2. C. Acarturk, F. Smit, R. de Graaf, A. van Straten, M. Ten Have, and P. Cuijpers Economic costs of social phobia: a population-based study J. Affect. Disord. 115 2009 421 429
3. AOK Bundesverband, 2008. Krankenhausbezogene Zusammenstellung der vereinbarten Basisfallwerte.
4. M.J. Azur, E.A. Stuart, C. Frangakis, and P.J. Leaf Multiple imputation by chained equations: what is it and how does it work? Int. J. Methods Psychiatry Res. 20 2011 40 49
5. A. Brooks, S.E. Hagen, S. Sathyanarayanan, A.B. Schultz, and D.W. Edington Presenteeism: critical issues J. Occup. Environ. Med. 52 2010 1055 1067
6. T.A. Brown, P. diNardo, and D.H. Barlow Anxiety Disorders Interview Schedule, Adult Version 1994 Oxford University Press Oxford, UK
7. D. Chisholm, M.R. Knapp, H.C. Knudsen, F. Amaddeo, L. Gaite, and B. van Wijngaarden Client socio-demographic and service receipt inventory - European version: development of an instrument for international research. EPSILON study 5. European psychiatric services: inputs linked to outcome domains and needs Br. J. Psychiatry 39 2000 S28 S33
8. D.M. Clark, and A. Wells A Cognitive Model of Social Phobia 1995 Guilford Press New York
9. Deutsche Krankenhausgesellschaft Bestandsaufnahme zur Krankenhausplanung und Investitionsfinanzierung in den Bundesländern 2009 Deutsche Krankenhausgesellschaft Berlin
10. P. Dolan Modeling valuations for EuroQol health states Med. Care 35 1997 1095 1108
11. L. Fehm, A. Pelissolo, T. Furmark, and H.U. Wittchen Size and burden of social phobia in Europe Eur. Neuropsychopharmacol. 15 2005 453 462
12. A.M. Gray Applied Methods of Cost-Effectiveness Analysis in Health Care 2011 Oxford University Press Oxford [u.a.]
13. E. Hedman, E. Andersson, B. Ljotsson, G. Andersson, C. Ruck, and N. Lindefors Cost-effectiveness of internet-based cognitive behavior therapy vs. cognitive behavioral group therapy for social anxiety disorder: results from a randomized controlled trial Behav. Res. Ther. 49 2011 729 736
14. E. Hedman, S. El Alaoui, N. Lindefors, E. Andersson, C. Ruck, A. Ghaderi, V. Kaldo, M. Lekander, G. Andersson, and B. Ljotsson Clinical effectiveness and cost-effectiveness of internet- vs. group-based cognitive behavior therapy for social anxiety disorder: 4-year follow-up of a randomized trial Behav. Res. Ther. 59 2014 20 29
15. S. Heinrich, M. Luppa, H. Matschinger, M.C. Angermeyer, S.G. Riedel-Heller, and H.H. Konig Service utilization and health-care costs in the advanced elderly Value Health 11 2008 611 620
16. J.S. Hoch All dressed up and know where to go: an example of how to use net benefit regression to do a cost-effectiveness analysis with person-level data (the 'A' in CEA) Clin. Neuropsychiatr. 5 2008 175 183
17. J.S. Hoch, A.H. Briggs, and A.R. Willan Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis Health Econ. 11 2002 415 430
18. J.S. Hoch, M.A. Rockx, and A.D. Krahn Using the net benefit regression framework to construct cost-effectiveness acceptability curves: an example using data from a trial of external loop recorders versus Holter monitoring for ambulatory monitoring of "community acquired" syncope BMC Health Serv. Res. 6 2006 68 76
19. InEK, 2008a. Fallpauschalenkatalog 2008.
20. InEK, 2008b. Datenbereitstellung gem. § 21 KHEntgG zum Zweck der Begleitforschung gem. § 17b Abs. 8 KHG, Datenjahr 2008.
21. J.M. Joesch, C.D. Sherbourne, G. Sullivan, M.B. Stein, M.G. Craske, and P. Roy-Byrne Incremental benefits and cost of coordinated anxiety learning and management for anxiety treatment in primary care Psychol. Med. 42 2012 1937 1948
22. K. Johnston, M.J. Buxton, D.R. Jones, and R. Fitzpatrick Assessing the costs of healthcare technologies in clinical trials Health Technol. Assess. 3 1999 1 76
23. Kassenärztliche Vereinigung Niedersachsen, 2008. Punktwerte für Psychotherapieleistungen in 2008, In: Leibing, E. (Ed.) (Personal Communication).
24. R.C. Kessler, M. Ames, P.A. Hymel, R. Loeppke, D.K. McKenas, D.E. Richling, P.E. Stang, and T.B. Ustun Using the world health organization health and work performance questionnaire (HPQ) to evaluate the indirect workplace costs of illness J. Occup. Environ. Med. 46 2004 S23 S37
25. R. Kilian Gesundheitsökonomische evaluation in der psychiatrischen Versorgungsforschung Prävent. Gesundheitsförderung 3 2008 135 144
26. A. Konnopka, F. Leichsenring, E. Leibing, and H.H. Konig Cost-of-illness studies and cost-effectiveness analyses in anxiety disorders: a systematic review J. Affect. Disord. 114 2009 14 31
27. S.M.H. Kopta, I. Kenneth, Jenny L. Lowry, and Larry E. Beutler Patterns of symptomatic recovery in psychotherapy J. Consult. Clin. Psychol. 62 1994 1009 1016
28. C. Krauth, F. Hessel, T. Hansmeier, J. Wasem, R. Seitz, and B. Schweikert Empirical standard costs for health economic evaluation in Germany - a proposal by the working group methods in health economic evaluation Gesundheitswesen 67 2005 736 746
29. F. Leichsenring, M. Beutel, and E. Leibing Psychodynamic psychotherapy for social phobia: a treatment manual based on supportive-expressive therapy Bull. Menni. Clin. 71 2007 56 83
30. F. Leichsenring, J. Hoyer, M. Beutel, S. Herpertz, W. Hiller, E. Irle, P. Joraschky, H.H. Konig, T.M. de Liz, B. Nolting, K. Pohlmann, S. Salzer, H. Schauenburg, U. Stangier, B. Strauss, C. Subic-Wrana, S. Vormfelde, G. Weniger, U. Willutzki, J. Wiltink, and E. Leibing The social phobia psychotherapy research network the first multicenter randomized controlled trial of psychotherapy for social phobia: rationale, methods and patient characteristics Psychother. Psychosom. 78 2009 35 41
31. F. Leichsenring, F. Leichsenring, S. Salzer, M.E. Beutel, S. Herpertz, W. Hiller, J. Hoyer, J. Huesing, P. Joraschky, B. Nolting, K. Poehlmann, V. Ritter, U. Stangier, B. Strauss, S. Tefikow, T. Teismann, U. Willutzki, J. Wiltink, and E. Leibing Long-term outcome of psychodynamic therapy and cognitive-behavioral therapy in social anxiety disorder Am. J. Psychiatry 171 2014 1074 1082
32. F. Leichsenring, S. Salzer, M.E. Beutel, S. Herpertz, W. Hiller, J. Hoyer, J. Huesing, P. Joraschky, B. Nolting, K. Poehlmann, V. Ritter, U. Stangier, B. Strauss, N. Stuhldreher, S. Tefikow, T. Teismann, U. Willutzki, J. Wiltink, and E. Leibing Psychodynamic therapy and cognitive-behavioral therapy in social anxiety disorder: a multicenter randomized controlled trial Am. J. Psychiatry 170 2013 759 767
33. H. Leicht, S. Heinrich, D. Heider, C. Bachmann, H. Bickel, H. van den Bussche, A. Fuchs, M. Luppa, W. Maier, E. Mosch, M. Pentzek, S.G. Rieder-Heller, F. Tebarth, J. Werle, S. Weyerer, B. Wiese, T. Zimmermann, H.H. Konig, and A.S. Grp Net costs of dementia by disease stage Acta Psychiatr. Scand. 124 2011 384 395
34. L. Luborsky Principles of Psychoanalytic Psychotherapy: Manual for Supportive-Expressive Treatment 1984 Basic Books New York
35. M. Luppa, S. Heinrich, H. Matschinger, A. Hensel, T. Luck, S.G. Riedel-Heller, and H.H. Koenig Direct costs associated with mild cognitive impairment in primary care Int. J. Geriatr. Psychiatry 23 2008 963 971
36. M. Luppa, S. Heinrich, H. Matschinger, H. Sandholzer, M.C. Angermeyer, H.H. Konig, and S.G. Riedel-Heller Direct costs associated with depression in old age in Germany J. Affect. Disord. 105 2008 195 204
37. T. Maljanen, P. Paltta, T. Harkanen, E. Virtala, O. Lindfors, M.A. Laaksonen, P. Knekt, and G. Helsinki Psychotherapy Study The cost-effectiveness of short-term psychodynamic psychotherapy and solution-focused therapy in the treatment of depressive and anxiety disorders during a one-year follow-up J. Ment. Health Policy Econ. 15 2012 13 23
38. D.S. Mennin, D.M. Fresco, R.G. Heimberg, F.R. Schneier, S.O. Davies, and M.R. Liebowitz Screening for social anxiety disorder in the clinical setting: using the Liebowitz social anxiety scale J. Anxiety Disord. 16 2002 661 673
39. J. Olesen, A. Gustavsson, M. Svensson, H.U. Wittchen, B. Jonsson, CDBE2010 Study Group, and European Brain Council The economic cost of brain disorders in Europe Eur. J. Neurol. 19 2012 155 162
40. S. Pilling, E. Mayo-Wilson, I. Mavranezouli, K. Kew, C. Taylor, D.M. Clark, and Guideline Development Group Recognition, assessment and treatment of social anxiety disorder: summary of NICE guidance Br. Med. J. 346 2013 f2541
41. K. Ponniah, and S.D. Hollon Empirically supported psychological interventions for social phobia in adults: a qualitative review of randomized controlled trials Psychol. Med. 38 2008 3 14
42. T.E. Raghunathan, J.M. Lepkowski, J. Van Hoewyk, and P. Solenberger A multivariate technique for multiply imputing missing values using a sequence of regression models Surv. Methodol. 27 2001
43. S. Ramsey, R. Willke, A. Briggs, R. Brown, M. Buxton, A. Chawla, J. Cook, H. Glick, B. Liljas, D. Petitti, and S. Reed Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA task force report Value Health 8 2005 521 533
44. Rote Liste Service GmbH, 2008. Rote Liste 2008. Arzneimittelverzeichnis für Deutschland. Rote Liste Service GmbH, Frankfurt am Main.
45. M. Sonntag, A. Konnopka, F. Leichsenring, S. Salzer, M.E. Beutel, S. Herpertz, W. Hiller, J. Hoyer, P. Joraschky, B. Nolting, K. Pohlmann, U. Stangier, B. Strauss, U. Willutzki, J. Wiltink, E. Leibing, and H.H. Konig Reliability, validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with social phobia Health Qual. Life Outcomes 11 2013 215
46. Stangier, U., Clark, D.M., Ehlers, A., 2006. Soziale Phobie: Fortschritte der Psychotherapie. Hogrefe, Goettingen.
47. Statistisches Bundesamt, 2009a. Kostennachweis der Krankenhäuser 2008. Statistisches Bundesamt, Wiesbaden.
48. Statistisches Bundesamt, 2009b. Grunddaten der Krankenhäuser 2008. Statistisches Bundesamt, Wiesbaden.
49. Statistisches Bundesamt, 2009c. Statistisches Jahrbuch 2009. Statistisches Bundesamt, Wiesbaden.
50. Statistisches Bundesamt, 2009d. Verdienste und Arbeitskosten. Statistisches Bundesamt, Wiesbaden.
51. Statistisches Bundesamt, 2010a. Verbraucherpreisindizes für Deutschland. Statistisches Bundesamt, Wiesbaden.
52. Statistisches Bundesamt, 2010b. Volkswirtschaftliche Gesamtrechnungen 2009. Statistisches Bundesamt, Wiesbaden.
53. N. Stulz, W. Lutz, S.M. Kopta, T. Minami, and S.M. Saunders Dose-effect relationship in routine outpatient psychotherapy: does treatment duration matter? J. Counc. Psychol. 60 2013 593 600
54. S. van Buuren, and K. Groothuis-Oudshoorn MICE: multiple imputation by chained equations in R J. Stat. Softw. 45 2011 1 67
55. Verband der Ersatzkassen Vergütungslisten für Logopädische/Sprachtherapeutische Leistungen 2001 Verband der Ersatzkassen (vdek) Berlin
56. Verband der Ersatzkassen Vergütungslisten für Ergotherapeutische Leistungen 2002 Verband der Ersatzkassen (vdek) Berlin
57. U. Willutzki, T. Teismann, and D. Schulte Psychotherapy for social anxiety disorder: long-term effectiveness of resource-oriented cognitive-behavioral therapy and cognitive therapy in social anxiety disorder J. Clin. Psychol. 68 2012 581 591
58. Wittchen, H.U., Zaudig, M., Fydrich, T., 1997. Strukturiertes Klinisches Interview für DSM-IV (SKID-I und SKID-II). Hogrefe, Goettingen.
59. N. Zethraeus, M. Johannesson, B. Jonsson, M. Lothgren, and M. Tambour Advantages of using the net-benefit approach for analysing uncertainty in economic evaluation studies Pharmacoeconomics 21 2003 39 48